Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study,Cell Proliferation

当前位置： X-MOL 学术 › Cell Prolif. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study
Cell Proliferation ( IF 5.9 ) Pub Date : 2020-11-17 , DOI: 10.1111/cpr.12947
Ying Feng _{1,

2} , Jianying Huang _{2,

3} , Jianyuan Wu _{2,

3} , Yan Xu ₄ , Bo Chen _{2,

3} , Lijun Jiang ₄ , Hui Xiang _{1,

2} , Zhiyong Peng _{1,

2} , Xinghuan Wang _{2,

3}

Affiliation

We aim to explore the safety and feasibility of umbilical cord mesenchymal stem cells (UC‐MSCs) transplantation in patients with severe and critically severe coronavirus disease‐2019 (COVID‐19).

中文翻译：